|
2021 Journal Article Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockadeMoisan, François, Oucherif, Sandra, Kaulanjan-Checkmodine, Priscilla, Prey, Sorilla, Rousseau, Benoît, Bonneu, Marc, Claverol, Stéphane, Gontier, Etienne, Lacomme, Sabrina, Dousset, Lea, Couffinhal, Thierry, Toutain, Jerome, Loot, Maya, Cario-André, Muriel, Jullié, Marie-Laure, Léauté-Labrèze, Christine, Taieb, Alain and Rezvani, Hamid Reza (2021). Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade. Proceedings of the National Academy of Sciences of the United States of America, 118 (7) e2018690118, 1-11. doi: 10.1073/pnas.2018690118 |
|
2021 Journal Article Drug-induced bullous lichenoid eruption: a side effect of nivolumab triggered by the TLR agonist imiquimodCostedoat, Ingrid, Vergara, R., Dousset, Lea, Gerard, Emilie, Prey, Sorilla, Dutriaux, Caroline, Beylot-Barry, Marie and Pham-Ledard, Anne (2021). Drug-induced bullous lichenoid eruption: a side effect of nivolumab triggered by the TLR agonist imiquimod. European Journal of Dermatology, 31 (1), 91-92. doi: 10.1684/ejd.2020.3951 |
|
2021 Journal Article Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective StudyValentin, Julie, Ferté, Thomas, Dorizy-Vuong, Valérie, Dousset, Léa, Prey, Sorilla, Dutriaux, Caroline, Pham-Ledard, Anne, Beylot-Barry, Marie and Gérard, Emilie (2021). Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective Study. Journal of Oncology, 2021 5524685, 1-8. doi: 10.1155/2021/5524685 |
|
2020 Journal Article Adverse events, need for hospitalization and systemic immunosuppression in very older patients (over 80 years) treated with anti-PD-1 for metastatic melanomaBarailler, Héloïse, Salomon, Guillemette, Dutriaux, Caroline, Prey, Sorilla, Gérard, Emilie, Dousset, Léa, Mertens, Cécile, Beylot-Barry, Marie, Meyer, Nicolas and Pham-Ledard, Anne (2020). Adverse events, need for hospitalization and systemic immunosuppression in very older patients (over 80 years) treated with anti-PD-1 for metastatic melanoma. Journal of Geriatric Oncology, 11 (8), 1340-1343. doi: 10.1016/j.jgo.2020.03.003 |
|
2020 Journal Article Impact on quality of life and autonomy of patients aged over 75 years treated with anti-PD-1 for metastatic melanoma: A single-centre prospective study Impact sur la qualité de vie et l'autonomie des patients de plus de 75 ans traités par anti-PD-1 pour un mélanome métastatique : étude prospective monocentriqueBarailler, H., Dousset, L., Mertens, C., Maurel, A., Gérard, E., Prey, S., Dutriaux, C., Beylot-Barry, M. and Pham-Ledard, A. (2020). Impact on quality of life and autonomy of patients aged over 75 years treated with anti-PD-1 for metastatic melanoma: A single-centre prospective study Impact sur la qualité de vie et l'autonomie des patients de plus de 75 ans traités par anti-PD-1 pour un mélanome métastatique : étude prospective monocentrique. Annales de Dermatologie et de Venereologie, 147 (11), 713-720. doi: 10.1016/j.annder.2020.07.012 |
|
2020 Journal Article Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing*Le Cleach, L., Dousset, L., Assier, H., Fourati, S., Barbarot, S., Boulard, C., Bourseau Quetier, C., Cambon, L., Cazanave, C., Colin, A., Kostrzewa, E., Lesort, C., Levy Roy, A., Lombart, F., Marco-Bonnet, J., Monfort, J. B., Samimi, M., Tardieu, M., Wolkenstein, P., Sbidian, E. and Beylot-Barry, M. (2020). Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing*. British Journal of Dermatology, 183 (5), 866-874. doi: 10.1111/bjd.19377 |
|
2020 Journal Article Synergistic effect of anti-PD1 immunotherapy then radiotherapy in advanced basal cell carcinoma Synergie de la séquence immunothérapie par anti-PD1 et radiothérapie au cours d'un carcinome basocellulaire avancéMalmontet, T., Dousset, L., Gerard, E., Ouhabrache, N., Pham-Ledard, A. and Beylot-Barry, M. (2020). Synergistic effect of anti-PD1 immunotherapy then radiotherapy in advanced basal cell carcinoma Synergie de la séquence immunothérapie par anti-PD1 et radiothérapie au cours d'un carcinome basocellulaire avancé. Annales de Dermatologie et de Venereologie, 147 (3), 228-232. doi: 10.1016/j.annder.2019.08.019 |
|
2019 Journal Article Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive studyManson, Guillaume, Maria, Alexandre Thibault Jacques, Poizeau, Florence, Danlos, François-Xavier, Kostine, Marie, Brosseau, Solenn, Aspeslagh, Sandrine, Du Rusquec, Pauline, Roger, Maxime, Pallix-Guyot, Maud, Ruivard, Marc, Dousset, Leá, Grignou, Laurianne, Psimaras, Dimitri, Pluvy, Johan, Quéré, Gilles, Grados, Franck, Duval, Fanny, Bourdain, Frederic, Maigne, Gwenola, Perrin, Julie, Godbert, Benoit, Taifas, Beatris Irina, Forestier, Alexandra, Voisin, Anne-Laure, Martin-Romano, Patricia, Baldini, Capucine, Marabelle, Aurélien, Massard, Christophe ... Michot, Jean-Marie (2019). Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study. Journal for ImmunoTherapy of Cancer, 7 (1) 337, 1-12. doi: 10.1186/s40425-019-0821-8 |
|
2019 Conference Publication Commonly Used Drugs in Rheumatology May Alter Anti-Tumoral Response to Immune Checkpoint InhibitorsKostine, Marie, Mauric, Eleonora, Barnetche, Thomas, Rouxel, Lea, Dutriaux, Caroline, Dousset, Lea, Prey, Sorilla, Beylot-Barry, Marie, Seneschal, Julien, Veillon, Remi, Charlotte, Vergnenegre, Daste, Amaury, Charlotte, Domblides, Sionneau, Baptiste, Gross-Goupi, Marine, Ravaud, Alain, Forcade, Edouard, Bannwarth, Bernard, Mehsen-Cetre, Nadia, Truchetet, Marie-Elise, Richez, Christophe and Schaeverbeke, Thierry (2019). Commonly Used Drugs in Rheumatology May Alter Anti-Tumoral Response to Immune Checkpoint Inhibitors. Annual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Professionals (ACR/ARP), Atlanta Ga, Nov 08-13, 2019. HOBOKEN: WILEY. |
|
2019 Journal Article UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesisHosseini, Mohsen, Dousset, Léa, Michon, Pauline, Mahfouf, Walid, Muzotte, Elodie, Bergeron, Vanessa, Bortolotto, Doriane, Rossignol, Rodrigue, Moisan, François, Taieb, Alain, Bouzier-Sore, Anne-Karine and Rezvani, Hamid R. (2019). UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesis. Oncogenesis, 8 (10) 52, 1-15. doi: 10.1038/s41389-019-0161-z |
|
2019 Journal Article Radiation-induced bullous lichen planus: An isomorphic manifestation of radiotherapyCirotteau, Paul, Lucas, Philippine, Dousset, L., Cales, Valérie, Gilliot, Olivier and Jouary, Thomas (2019). Radiation-induced bullous lichen planus: An isomorphic manifestation of radiotherapy. Acta Dermato-Venereologica, 99 (11), 1033-1034. doi: 10.2340/00015555-3258 |
|
2019 Journal Article Loss of Epidermal HIF-1α Blocks UVB-Induced Tumorigenesis by Affecting DNA Repair Capacity and Oxidative StressMahfouf, W., Hosseini, Mohsen, Muzotte, Elodie, Serrano-Sanchez, Martin, Dousset, Lea, Moisan, François, Rachidi, W., Taieb, A., Rudolf, Jana and Rezvani, Hamid Reza (2019). Loss of Epidermal HIF-1α Blocks UVB-Induced Tumorigenesis by Affecting DNA Repair Capacity and Oxidative Stress. Journal of Investigative Dermatology, 139 (9), 2016-2028.e7. doi: 10.1016/j.jid.2019.01.035 |
|
2019 Journal Article Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapiesDousset, Léa, Boniface, Katia and Seneschal, Julien (2019). Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies. Giornale Italiano di Dermatologia e Venereologia, 154 (4), 435-443. doi: 10.23736/S0392-0488.18.06254-5 |
|
2019 Journal Article Response to: 'Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and BassKostine, Marie, Dousset, Léa and Schaeverbeke, Thierry (2019). Response to: 'Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass. Annals of the Rheumatic Diseases, 78 (7) e71, 1-1. doi: 10.1136/annrheumdis-2018-213682 |
|
2019 Conference Publication COMMONLY USED DRUGS IN RHEUMATOLOGY MAY ALTER ANTI-TUMORAL RESPONSE TO IMMUNE CHECKPOINT INHIBITORSKostine, Marie, Mauric, Eleonora, Barnetche, Thomas, Rouxel, Lea, Dutriaux, Caroline, Dousset, Lea, Prey, Sorilla, Beylot-Barry, Marie, Seneschal, Julien, Veillon, Remi, Vergnenegre, Charlotte, Daste, Amaury, Domblides, Charlotte, Sionneau, Baptiste, Gross-Goupil, Marine, Ravaud, Alain, Forcade, Edouard, Bannwarth, Bernard, Truchetet, Marie-Elise, Richez, Christophe, Mehsen-Cetre, Nadia and Schaeverbeke, Thierry (2019). COMMONLY USED DRUGS IN RHEUMATOLOGY MAY ALTER ANTI-TUMORAL RESPONSE TO IMMUNE CHECKPOINT INHIBITORS. Annual European Congress of Rheumatology (EULAR), Madrid Spain, Jun 12-15, 2019. LONDON: BMJ PUBLISHING GROUP. doi: 10.1136/annrheumdis-2019-eular.7470 |
|
2019 Journal Article Long-lasting cutaneous tuberculosis owing to Mycobacterium bovis masquerading as sarcoidosisDequidt, Laure, Dousset, Léa, Pham-Ledard, Anne, Doutre, Marie-Sylvie and Beylot-Barry, Marie (2019). Long-lasting cutaneous tuberculosis owing to Mycobacterium bovis masquerading as sarcoidosis. JAAD Case Reports, 5 (1), 1-4. doi: 10.1016/j.jdcr.2018.07.020 |
|
2018 Journal Article Skins cancers Les cancers cutanésDousset, Léa (2018). Skins cancers Les cancers cutanés. Actualites Pharmaceutiques, 57 (581), 24-26. doi: 10.1016/j.actpha.2018.10.005 |
|
2018 Journal Article Energy Metabolism Rewiring Precedes UVB-Induced Primary Skin Tumor FormationHosseini, Mohsen, Dousset, Léa, Mahfouf, Walid, Serrano-Sanchez, Martin, Redonnet-Vernhet, Isabelle, Mesli, Samir, Kasraian, Zeinab, Obre, Emilie, Bonneu, Marc, Claverol, Stephane, Vlaski, Marija, Ivanovic, Zoran, Rachidi, Walid, Douki, Thierry, Taieb, Alain, Bouzier-Sore, Anne-Karine, Rossignol, Rodrigue and Rezvani, Hamid Reza (2018). Energy Metabolism Rewiring Precedes UVB-Induced Primary Skin Tumor Formation. Cell Reports, 23 (12), 3621-3634. doi: 10.1016/j.celrep.2018.05.060 |
|
2018 Journal Article Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer - Clinical aspects and relationship with tumour response: A single-centre prospective cohort studyKostine, Marie, Rouxel, Leá, Barnetche, Thomas, Veillon, Rémi, Martin, Florent, Dutriaux, Caroline, Dousset, Leá, Pham-Ledard, Anne, Prey, Sorilla, Beylot-Barry, Marie, Daste, Amaury, Gross-Goupil, Marine, Lallier, Julie, Ravaud, Alain, Forcade, Edouard, Bannwarth, Bernard, Truchetet, Marie-Elise, Richez, Christophe, Mehsen, Nadia and Schaeverbeke, Thierry (2018). Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer - Clinical aspects and relationship with tumour response: A single-centre prospective cohort study. Annals of the Rheumatic Diseases, 77 (3), 393-398. doi: 10.1136/annrheumdis-2017-212257 |
|
2017 Journal Article Treatment of Hailey-Hailey disease with botulinic toxin: A retrospective study of 8 cases Traitement de la maladie de Hailey-Hailey par toxine botulique : étude rétrospective de huit casDousset, L., Pham-Ledard, A., Doutre, M. S., Beylot-Barry, M. and Cogrel, O. (2017). Treatment of Hailey-Hailey disease with botulinic toxin: A retrospective study of 8 cases Traitement de la maladie de Hailey-Hailey par toxine botulique : étude rétrospective de huit cas. Annales de Dermatologie et de Venereologie, 144 (10), 599-606. doi: 10.1016/j.annder.2017.05.014 |
